GSE65634 resveratrol fibroblast 6 v 3 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE65634_resveratrol_fibroblast_6_v_3_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE65634_resveratrol_fibroblast_6_v_3_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE65634_resveratrol_fibroblast_6_v_3_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE65634_resveratrol_fibroblast_6_v_3_human_up.

Results found

Linked to

 

Label

Description

 

Gene

acetylserotonin O-methyltransferase like

Gene

MIR4435-2 host gene

Gene

general transcription factor IIi pseudogene 4

Gene

long intergenic non-protein coding RNA 662

Gene

mir-100-let-7a-2-mir-125b-1 cluster host gene

Gene

CDH13 antisense RNA 2

Gene

MT-ATP6 pseudogene 1

Gene

MT-ND2 pseudogene 28

Gene

CYP1B1 antisense RNA 1

Gene

long intergenic non-protein coding RNA 886

  • Gene

    acetylserotonin O-methyltransferase like



  • Gene

    general transcription factor IIi pseudogene 4


  • Gene

    long intergenic non-protein coding RNA 662


  • Gene

    mir-100-let-7a-2-mir-125b-1 cluster host gene


  • Gene

    CDH13 antisense RNA 2


  • Gene

    MT-ATP6 pseudogene 1


  • Gene

    MT-ND2 pseudogene 28


  • Gene

    CYP1B1 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 886

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.